SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-030395
Filing Date
2018-12-03
Accepted
2018-12-03 14:10:45
Documents
3
Period of Report
2018-12-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K DECEMBER 2018 ASH PRESENTATION snss-8k_20181202.htm 8-K 33404
2 EX-99.1 PRESS RELEASE DATED DECEMBER 2, 2018. snss-ex991_6.htm EX-99.1 23344
3 GRAPHIC gmobq0cyrqkj000001.jpg GRAPHIC 2773
  Complete submission text file 0001564590-18-030395.txt   61970
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 181213688
SIC: 2834 Pharmaceutical Preparations